|
|
Lung cancer community connects #TogetherSeparately during pandemic
|
COVID-19 has changed our way of life. Everyone is looking for information about how to stay safe and healthy, but those affected by lung cancer have a sense of urgency others can only imagine. A livestream series is giving them an opportunity to connect face-to-face, meet experts, and talk about their unique questions and challenges. View short clips and register for the April 23 live talk at LCRF.org/together.
|
|
|
|
|
|
|
|
Executive Director's Update
|
| LCRF Executive Director Dennis Chillemi is sending a weekly video message to LCRF supporters. Here's a link to today's update, which is also being posted on our social media channels. |
|
|
|
|
|
|
|
Let's hear it for... Our #TogetherSeparately live talk and roundtable moderators, who have taken time out of their busy schedules to share their knowledge: Dr. Chad Pecot; Dr. Mark Kris; Ali Schaffer, LCSW; Sarah Cassidy; and Dr. David Spigel.
|
|
|
Lung Cancer Community on Facebook
|
|
The #TogetherSeparately livestream has given hundreds of people who care about lung cancer a place to discuss their concerns. You're invited to keep the conversation going by joining the Lung Cancer Community group on Facebook. Join us and introduce yourself!
|
|
|
|
|
|
|
|
New immunotherapy drug for SCLC
|
|
The FDA approved immunotherapy drug durvalumab (Imfinzi) in combination with chemotherapy for the first-line treatment of extensive stage small cell lung cancer (SCLC). This is now the 4th immunotherapy drug approved to treat SCLC, which expands the options for treatment of this aggressive type of lung cancer. The rapid pace of FDA approvals in recent years is a testament to the importance of research.
|
|
|
|
|
|
|
|
“Tomorrow, I’m going to WIN The Day.”
|
|
Frank, a personal trainer, was diagnosed with stage IV lung cancer after a persistent cough led him to get a chest x-ray. Now he uses his fitness platform to help others facing a cancer diagnosis.
|
|
|
|
|
|
|
